COMPANY

Anodyne Nanotech

Keywords: transdermal metabolic disease of metabolism obesity

Location: Boston, MA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $12.6M (Form D filed Jun 11, 2026). SEC Form D 0001818572-26-000003 (Jun 11, 2026)
Evidence (1 event)
- Jun 11, 2026 · SEC Form D 0001818572-26-000003
  Name of Issuer: Anodyne Nanotech, Inc.; CIK: 1818572; Address: Boston, MA; Submission type: D; Filing date: 2026-06-11; Industry Group: Other Health Care; Date of First Sale: 2026-05-27; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 17259023; Total Amount Sold: 12597058; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals